A new trial finds that intravenous immunoglobulin stabilises kidney function and slows damage in patients with chronic ...

SCTIMST transfers 5 medical device technologies to industry, including DBS system, electrodes, plasma fractionation, and wound dressings.

Circulate Health, the company dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan, today announces the publication of a single blind, ...

Octapharma has released the results from its prospective, randomized, double-blind, parallel group, crossover, placebo-controlled phase 3 study comparing the effectiveness of PANZYGA® (immune globulin ...

The trial used a double-blind, double-dummy technique in that all patients received both an oral and an intravenous preparation. Patients were allocated to active 1 g (2×500 mg) paracetamol (Panadol, ...

Objective: To compare the effect of the design and implementation of systems for the preparation and administration of intravenous therapy in hospitals in three European countries on the number of ...

Richard Oehler, MD, Assistant Professor, Director of Clinical Education, College of Medicine, Division of Infectious Disease, University of South Florida, Tampa, FL Linda W. Kam, PharmD BCPS ...

Similarly, it was thought that intravenous immunoglobulin (IVIG)—holding multiple immunomodulatory effects—would provide clinically favorable results, but recent studies suggest otherwise. Still, the ...

A draft DSR is untenable for grant of an EC. (iv). Preparation of reports and appraisal of projects by DEIAA and DEAC shall be on the basis of a valid and a subsisting DSR. (v). DEIAA and DEAC are ...